Loading insider details...
Beta
Latest Form 4 (Jun 24, 2026): Grant/Award of 2,333 LONA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | LeonaBio, Inc. (LONA) | Grant/Award | 2,333 | n/a |
| May 8, 2026 | LeonaBio, Inc. (LONA) | Grant/Award | 56,000 | n/a |
| Jan 23, 2026 | Astria Therapeutics, Inc. (ATXS) | Disposition to Issuer | 14,166 | n/a |
| Jun 12, 2025 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 26,550 | n/a |
| Jun 6, 2024 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 14,100 | n/a |
| May 23, 2024 | Landos Biopharma, Inc. (LABP) | Disposition to Issuer | 1,800 | n/a |
| Jun 6, 2023 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 14,100 | n/a |
| Jun 9, 2022 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 8,333 | n/a |
| Jun 2, 2021 | CATABASIS PHARMACEUTICALS INC (CATB) | Grant/Award | 85,000 | n/a |
| Feb 3, 2021 | CATABASIS PHARMACEUTICALS INC (CATB) | Grant/Award | 1,617 | $4.87M |